| Financial Year |
March 31 2023 |
| Monetary Funds |
234,219,949.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
149,760,762.05 |
| Advances to Suppliers |
16,811,831.30 |
| Other Receivables |
60,174,643.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,434,354,059.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
150,443,729.53 |
| Total Current Assets |
3,045,764,975.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,203,267.16 |
| Investment Properties |
52,733,383.64 |
| Fixed Assetes |
239,175,474.39 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,947,034.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,838,504.12 |
| Deferred Income Tax Assets |
11,134,569.55 |
| Other Non-Current Assets |
5,816,561.00 |
| Sub-Total of Non-Current Assets |
411,723,601.97 |
| Total Assets |
3,457,488,577.25 |
| Short-Term Loans |
929,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
16,774,273.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,500.58 |
| Taxes Payable |
29,529,967.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
233,238,691.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,559,871.72 |
| Other Current Liabilities |
474,681,367.42 |
| Sub-Total of Current Liabilities |
2,036,792,703.35 |
| Long-term Loans |
25,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,765,217.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,360,715.85 |
| Total Liabilities |
2,113,153,419.20 |
| Paid-In Capital(Or Share Stock) |
256,156,000.00 |
| Capital Surplus |
296,479,951.83 |
| Surplus Reserve |
36,184,019.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
778,180,568.78 |
| Minority Stockholder's Interest |
-27,625,514.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,371,960,672.46 |
| Owner's Equity（Stockholder's Equity） |
1,344,335,158.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,457,488,577.25 |
